News

September 1, 2016September 1, 2016

Debate on Stem Cell Therapy for Pulmonary Fibrosis Heats Up as FDA Hearings Near

COPD, Idiopathic Pulmonary Fibrosis, News

As the U.S. Food and Drug Administration (FDA) readies a public hearing on stem cell therapy regulation, an ongoing debate over the clinical application of stem cell therapy has been heating ... Read more

August 30, 2016August 30, 2016

Clinicians Debate Management, Diagnosis of Respiratory Illnesses in Middle East

Asthma, COPD, Idiopathic Pulmonary Fibrosis, News

Leading medical professionals of European, Middle Eastern and African countries gathered at Boehringer Ingelheim’s second regional respiratory forum, themed “Innovative Solutions to Help Millions,” in Dubai to debate the clinical practices of ... Read more

August 29, 2016August 29, 2016

Boehringer Ingelheim and Duke Research Institute Expand IPF Patient Registry

News

Boehringer Ingelheim Pharmaceuticals and the Duke Clinical Research Institute (DCRI) are expanding the Idiopathic Pulmonary Fibrosis PROspective Outcomes Registry (IPF-PRO), which they say will make it the largest IPF patient registry in the country. The ... Read more

August 26, 2016August 26, 2016

Vanderbilt’s IPF Researchers Awarded $11M Grant to Study Genetics of Disease

Idiopathic Pulmonary Fibrosis, News

The National Heart, Lung and Blood Institute (NHLBI) has awarded Vanderbilt University Medical Center (VUMC) an $11 million project renewal grant to study the genetics and biological mechanisms behind idiopathic pulmonary ... Read more

August 25, 2016August 25, 2016

2 Therapies Intended for Other Diseases May Work to Treat PH

News, Pulmonary Hypertension

A team of researchers at the University of Pittsburg and UPMC (University of Pittsburg Medical Center) identified a new group of compounds that could improve the stiffness of blood vessels ... Read more

August 24, 2016August 24, 2016

Time-honored Device, Digital Platform Combo to Revolutionize Home Respiratory Care

Asthma, COPD, News

PN Medical, a pulmonary speech technology company, and home care clinical software developer Orbita, are partnering to develop PN Medical’s next-generation Breather+ respiratory muscle training (RMT) device for remote care management. Sensors embedded in Breather+ ... Read more

August 23, 2016August 23, 2016

Cinqaero (Reslizumab) for Severe Asthma Granted EC Marketing Authorization

Asthma, News

The European Commission (EC) has granted marketing authorization for Teva Pharmaceutical’s Cinqaero (reslizumab) in all European Union (EU) nations, Norway, Liechtenstein, and Iceland. The therapy treats inadequately controlled asthma in adult and ... Read more

August 22, 2016August 22, 2016

FDA Grants Orphan Drug Status to Pulmatrix’s PUR1900 for Cystic Fibrosis Fungal Lung Infections

Cystic Fibrosis, News

The U.S. Food & Drug Administration (FDA) has granted orphan drug designation to Pulmatrix‘s PUR1900, an inhaled drug for the treatment of pulmonary fungal infections in patients with cystic fibrosis (CF). ... Read more

August 19, 2016August 19, 2016

National Asthma and Lung Groups Collaborate to Empower Patients, Raise Awareness About Disease Severity

Asthma, News

The Allergy & Asthma Network recently partnered with the CHEST Foundation for a joint campaign to empower patients with persistent, difficult-to-control asthma. The campaign hopes to increase patients’ understanding of their condition through special ... Read more

August 18, 2016August 18, 2016

Lung Cancer Type and Severity Better Seen by Computers Than Pathologists, Study Reports

Lung Cancer, News

Computer analysis of slides containing lung cancer tissue samples increases the accuracy of tumor classification and patient prognoses, according to a new study conducted at Stanford University School Of Medicine in ... Read more